Article
Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones In Vitro.
Antimicrobial agents and chemotherapy - 19 Apr 2022
Kim Hyun, Mori Shigetarou, Kenri Tsuyoshi, Suzuki Yasuhiko
Abstract excerpt
Buruli ulcer disease is a neglected necrotizing and disabling cutaneous tropical illness caused by Mycobacterium ulcerans. Fluoroquinolone (FQ), used in the treatment of this disease, has been known to act by inhibiting the enzymatic activities of DNA gyrase. However, the detailed molecular basis of these characteristics and the FQ resistance mechanisms in M. ulcerans remains unknown. This study investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
